Moneycontrol Be a Pro
Get App
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Venus Remedies

Venus Remedies

BSE: 526953|NSE: VENUSREM|ISIN: INE411B01019|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Dec 06, 16:00
23.50
-1.2 (-4.86%)
VOLUME 1,014
LIVE
NSE
Dec 06, 15:32
23.20
-0.45 (-1.9%)
VOLUME 1,658
News on Venus Remedies
Select Year: 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Buy Venus Remedies: Sukhani 

2.08 pm | 08 Dec 2009 |  Source: CNBC-TV18

Buy Venus Remedies, says Technical Analyst, Sudarshan Sukhani....

Venus Remedies has target of Rs 245: Sukhani 

9.56 am | 08 Dec 2009 |  Source: CNBC-TV18

Venus Remedies has target of Rs 245, says Technical Analyst, Sudarshan Sukhani....

Bull's Eye: Stocks to buy today 

8.57 am | 08 Dec 2009 |  Source: Moneycontrol.com

Everyday, on this special segment, Bull's Eye, CNBC-TV18 brings you trading/investing calls from investment analysts. Today, we bring you calls from:...

Venus Remedies outlicenses Sulbactomax to South Korean co 

2.47 pm | 23 Sep 2009 |  Source: CNBC-TV18

The company outlicenses Sulbactomax an anti-infective drug which will take care of the resistance in antibiotics, to South Korean company, says it...

Buy Venus Remedies, target of Rs 275: Emkay

6.54 pm | 11 May 2009 |  Source: Moneycontrol.com

Emkay Global Financial Services has maintained its buy rating on Venus Remedies with a target price of Rs 275. Venus reported a muted growth of 1% in ...

1
Quick Links for Venus Remedies
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.